Plasma angiotensin II, arginine vasopressin and atrial natriuretic peptide in free ranging and captive seals and sea lions. 1998

T Zenteno-Savin, and M A Castellini
Institute of Marine Science, University of Alaska Fairbanks, USA.

We used radioimmunoassay methods to quantify arginine vasopressin (AVP), atrial natriuretic peptide (ANP), and angiotensin II (Ang II) in plasma samples from harbor seals (Phoca vitulina richardsii), Weddell seals (Leptonychotes weddellii), northern elephant seals (Mirounga angustirostris), ringed seals (Phoca hispida), California sea lions (Zalophus californianus), and Steller sea lions (Eumetopias jubatus). Plasma concentrations of AVP, ANP, and Ang II in these pinniped species were within the ranges reported for other vertebrates under resting conditions. However, there were species, geographic and developmental variations in these hormones: Levels of AVP in plasma samples from adult Steller sea lions and harbor seals were higher than in pups of the same species; higher levels of plasma ANP were found in wild captured Alaskan Steller sea lions and in hunted ringed seals; differences in plasma levels of all three hormones were found throughout the geographic distribution of harbor seals and Steller sea lions in Alaska. This is the first report on circulating concentrations of vasoactive hormones in pinnipeds, and demonstrates that further studies are needed to ascertain the natural variability in these levels with the impact of molting, fasting, diving and environmental factors in seals and sea lions.

UI MeSH Term Description Entries
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D046070 Sea Lions A group comprised of several species of aquatic carnivores in different genera, in the family Otariidae. In comparison to FUR SEALS, they have shorter, less dense hair. California Sea Lion,Sea Lion, California,Zalophus,Sealions,Zalophus californianus,California Sea Lions,Lion, California Sea,Lion, Sea,Lions, California Sea,Lions, Sea,Sea Lion,Sea Lions, California,Sealion

Related Publications

T Zenteno-Savin, and M A Castellini
March 2011, American journal of physiology. Regulatory, integrative and comparative physiology,
T Zenteno-Savin, and M A Castellini
March 1989, The American journal of physiology,
T Zenteno-Savin, and M A Castellini
April 2006, Diseases of aquatic organisms,
T Zenteno-Savin, and M A Castellini
January 1988, Peptides,
T Zenteno-Savin, and M A Castellini
August 1993, Acta psychiatrica Scandinavica,
T Zenteno-Savin, and M A Castellini
September 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!